Drug Database
Back to search

Netherlands· NL-4d7f3daf7599

HBVAXPRO 10 microgram/ml, suspensie voor injectie in flacon

A hepatitis b, gereinigtes antigen product containing hepatitis b oppervlakte antigeen, recombinant (hbsag), registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC J07BC01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedHBVAXPRO 10 microgram/ml, suspensie v…ATCJ07BC01REGISTER NO.NL-4d7f3daf7599PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hepatitis b oppervlakte antigeen, recombinant (hbsag)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hepatitis b, gereinigtes antigen is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BC01 (hepatitis b, gereinigtes antigen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search hepatitis b, gereinigtes antigen products by name

Hepatitis b, gereinigtes antigen · ATC J07BC01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HEPATITIS B OPPERVLAKTE ANTIGEEN, RECOMBINANT (HBsAg)
Manufacturer
Merck Sharp & Dohme B.V.
Country
Netherlands (NL)
ATC code
J07BC01
ATC class
Hepatitis B, gereinigtes Antigen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/01/183

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

255 interactions on record for hepatitis b, gereinigtes antigen.

Graded by severity as the source publishes them — 255 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hepatitis b, gereinigtes antigen against other medicinesHow interaction checks work

Hepatitis b, gereinigtes antigen · interactions on record

255 records

  • 255 moderate

Most severe, free to view

  • PrednisoloneA07EA01moderate
  • HydrocortisoneA07EA02moderate
  • PrednisoneA07EA03moderate
  • BetamethasoneA07EA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hepatitis b, gereinigtes antigen in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hepatitis b, gereinigtes antigen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4168d47-2e32-4ee0-809c-26530c8aa90a
GET /v1/drugs/c4168d47-2e32-4ee0-809c-26530c8aa90a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/hbvaxpro-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Hepatitis B, Purified Antigen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71151",
  "excipients": [
    "ALUMINIUMHYDROXYFOSFAATSULFAAT",
    "BORAX 10-WATER (E 285)",
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "HEPATITIS B OPPERVLAKTE ANTIGEEN, RECOMBINANT (HBsAg)"
  ],
  "leaflet_url": null,
  "authorised_at": "2001/04/27",
  "procedure_number": "EMEA/H/C/000373",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/01/183",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about hepatitis b, gereinigtes antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console